Semaglutide Raw Powder

Semaglutide raw powder is the core active ingredient in the preparation of various semaglutide raw powderfinished formulations. Pre-filled injection pens and oral tablets used daily by patients are processed from it. Pharmacologically, this ingredient can intelligently regulate insulin secretion according to blood glucose levels, exerting its effect when blood glucose is high and stabilizing when blood glucose is normal, effectively avoiding the risk of hypoglycemia that is common with traditional hypoglycemic drugs. Simultaneously, it can slow gastrointestinal emptying and act on the appetite regulation area of ​​the brain, helping users achieve a sustained feeling of fullness, thus providing weight management benefits in addition to lowering blood glucose.

In terms of dosage form design, relying on the stable properties of this powder, mainstream products now achieve a once-weekly injection dosing regimen, significantly reducing the medication burden on patients compared to the previous daily injection schedule. The advent of oral versions also provides an alternative for patients who fear injections, making this medication accessible to a wider population.

1. Type 2 Diabetes Patients
Primarily used for glycemic control in adults with type 2 diabetes, especially those whose blood glucose levels remain uncontrolled despite diet and exercise, or those who have not responded well to oral hypoglycemic agents such as metformin. Additionally, for type 2 diabetes patients with cardiovascular disease or chronic kidney disease, this medication can reduce the risk of cardiovascular events and the progression of kidney damage.

2. Overweight/Obese Individuals Requiring Weight Management
In regions with approved weight loss indications (such as the United States), the target population includes:

• Obese individuals with a BMI ≥ 30 kg/m²;
• Overweight individuals with a BMI ≥ 27 kg/m² and at least one weight-related comorbidity (such as hypertension, hyperlipidemia, type 2 diabetes, sleep apnea, etc.).

Furthermore, obese adolescents aged 12 years and older are also included in the scope of application in the United States.

Key Population: For patients with both type 2 diabetes and obesity, this medication offers a dual therapeutic benefit, making them the core target beneficiary group in clinical practice.

Exclusion criteria: Contraindicated in individuals with a history or family history of medullary thyroid carcinoma, and patients with type 2 multiple endocrine neoplasia syndrome; not suitable for patients with type 1 diabetes, pregnant or lactating women, patients with severe gastrointestinal diseases, and children under 18 years of age (except for weight loss indications).

1. Two Technical Routes for Production Process

The chemical solid-phase synthesis method couples amino acids using an automated synthesizer, resulting in high purity and controllable impurities. The bio-fermentation method utilizes high-density fermentation with genetically engineered bacteria, suitable for large-scale production and with lower costs. Both routes require further purification before drug use.

2. Core Purification and Forming Steps

After microfiltration, the crude peptides are purified using a two-step reversed-phase high-performance liquid chromatography (RP-HPLC) process, achieving a purity of over 99% and single impurities below 0.1%-0.15%. The purified solution is then concentrated and lyophilized or spray-dried to produce a loose powder.

3. Process Control Targeting Molecular Structure

To prevent oxidative degradation of non-natural amino acids and fatty acid modification groups, the process controls the pH to 6.5-9.0 and uses inert gas protection. Simultaneously, optimized folding conditions ensure correct disulfide bond pairing, guaranteeing product activity.

4. Industrial-Grade Manufacturing and Automated Control

The process employs industrial-grade reaction vessels of several hundred liters and a preparative-grade chromatography system, with a single batch processing capacity of kilograms. The PLC/DCS system monitors process parameters in real time, adhering to SOPs and GMP standards throughout the entire process, enabling complete traceability from raw materials to finished products.

Overview of Key Process Steps and Control Parameters

1.Dual Cardio- and Renal Protective Effects

Semaglutide raw powder significantly reduces the risk of major adverse cardiovascular events in patients with type 2 diabetes and cardiovascular disease, while simultaneously slowing the decline in glomerular filtration rate in patients with chronic kidney disease. Its cardio- and renal protective effects are partially independent of its glucose-lowering effect, providing significant clinical value for the long-term management of diabetic complications.

2. Comprehensive Improvement of Metabolic Syndrome

In addition to its core glucose-lowering and weight-loss effects, this drug also provides additional benefits such as lower systolic blood pressure, improved lipid profile (reduction in total cholesterol and triglycerides), and improvement of non-alcoholic fatty liver disease. It helps reduce overall cardiovascular risk scores and achieves comprehensive regulation of multiple metabolic abnormalities.

3. Potential for Adjunctive Improvement of Polycystic Ovary Syndrome (PCOS) in Women

For PCOS patients with obesity or insulin resistance, semaglutide raw powder may help restore menstrual cycle regularity, reduce androgen levels, and improve ovulation function, in addition to weight loss and improved insulin sensitivity.